Pentwater Capital Management’s ADC Therapeutics ADCT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$320K	–	279
2020 Q4	$320K	Hold	10,000	–	–	﹤0.01%	172
2020 Q3	$330K	Buy	+10,000	New	+$330K	﹤0.01%	163